Effect of zinc, copper, and calcium on the structure and stability of serum amyloid A

Biochemistry

Volumn 46, Issue 18, 2007, Pages 5562-5569

  Wang, Limin ^a   Colón, Wilfredo ^a  

^a Research Rensselaer Polytechnic Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGGLOMERATION; CONCENTRATION (PROCESS); DISEASES; METABOLISM; MOLECULAR STRUCTURE; MONOMERS;

HOMEOSTASIS CONDITIONS; MONOMELIC SPECIES; PRECARIOUS STRUCTURE;

PROTEINS;

CALCIUM; COPPER; MONOMER; SERUM AMYLOID A; ZINC;

ANALYTIC METHOD; AQUEOUS SOLUTION; ARTICLE; HOMEOSTASIS; INCUBATION TIME; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SECONDARY STRUCTURE; PROTEIN STABILITY; PROTEIN STRUCTURE;

ACUTE-PHASE REACTION; ANIMALS; CALCIUM; COPPER; HOMEOSTASIS; LIGANDS; MICE; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DENATURATION; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; SERUM AMYLOID A PROTEIN; STRUCTURE-ACTIVITY RELATIONSHIP; ZINC;

MURINAE;

EID: 34248165082     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi602629y     Document Type: Article

References (67)

1. Malle, E., and de Beer, F. C. (1996) Human serum amyloid A (SAA) protein: A prominent acute phase reactant for clinical practice, Eur. J. Clin. Invest. 26, 427-435.
2. Uhlar, C. M., and Whitehead, A. S. (1999) Serum amyloid A, the major vertebrate acute-phase reactant, Eur. J. Biochem. 265, 501-523.
3. Uhlar, C. M., Burgess, C. J., Sharp, P. M., and Whitehead, A. S. (1994) Evolution of the serum amyloid A (SAA) protein superfamily, Genomics 19, 228-235.
4. McAdam, K. P. W. J., and Sipe, J. D. (1976) Murine model for human secondary amyloidosis: Genetic variability of the acute-phase serum protein SAA response to endotoxins and casein, J. Exp. Med. 144, 1121-1127.
5. De Beer, F. C., Mallya, R. K., Fagan, E. A., Lanham, J. G., Hughes, G. R., and Pepys, M. B. (1982) Serum amyloid-A protein concentration in inflammatory diseases and its relationship to the incidence of reactive systemic amyloidosis, Lancet 2, 213-234.
6. Meek, R. L., Urieli-Shoval, S., and Benditt, E. P. (1994) Expression of apolipoprotein serum amyloid A mRN A in human atherosclerotic lesions and cultured vascular cells: Implications for serum amyloid A function, Proc. Natl. Acad. Sci. U.S.A. 91, 3186-3190.
7. Urieli-Shoval, S., Meek, R. L., Hanson, R. H., Eriksen, N., and Benditt, E. P. (1994) Human serum amyloid A genes are expressed in monocyte/macrophage cell lines, Am. J. Pathol. 145, 650-660.
8. Urieli-Shoval, S., Cohen, P., Eisenberg, S., and Matzner, Y. (1998) Widespread expression of serum amyloid A in histologically normal human tissues. Predominant localization to the epithelium, J. Histochem. Cytochem. 46, 1377-1384.
9. O'Hara, R., Murphy, E. P., Whitehead, A. S., FitzGerald, O., and Bresnihan, B. (2000) Acute-phase serum amyloid A production by rheumatoid arthritis synovial tissue, Arthritis Res. 2, 142-144.
10. Kumon, Y., Suehiro, T., Hashimoto, K., Nakatani, K., and Sipe, J. D. (1999) Local expression of acute phase serum amyloid A mRNA in rheumatoid arthritis synovial tissue and cells, J. Rheumatol. 26, 785-790.
11. Thorn, C. F., Lu, Z. Y., and Whitehead, A. S. (2003) Tissue-specific regulation of the human acute-phase serum amyloid A genes, SAA1 and SAA2, by glucocorticoids in hepatic and epithelial cells, Eur. J. Immunol. 33, 2630-2639.
12. Tanaka, F., Migita, K., Kawabe, Y., Aoyagi, T., Ida, H., Kawakami, A., and Eguchi, K. (2004) Interleukin-18 induces serum amyloid A (SAA) protein production from rheumatoid synovial fibroblasts, Life Sci. 74, 1671-1679.
13. Upragarin, N., Landman, W. J., Gaastra, W., and Gruys, E. (2005) Extrahepatic production of acute phase serum amyloid A, Histol. Histopathol. 20, 1295-1307.
14. Gonzalez, S. F., Buchmann, K., and Nielsen, M. E. (2006) Ichthyophthirius multifiliis infection induces massive up-regulation of serum amyloid A in carp (Cyprinus carpio), Vet. Immunol. Immunopathol. 115, 172-178.
15. Libby, P., Ridker, P. M., and Maseri, A. (2002) Inflammation and atherosclerosis, Circulation 105, 1135-1143.
16. Marx, J. (2004) Inflammation and cancer: The link grows stronger, Science 306, 966-968.
17. Tuppo, E. E., and Arias, H. R. (2005) The role of inflammation in Alzheimer's disease, Int. J. Biochem. Cell Biol. 37, 289-305.
18. Aggarwal, B. B., Shishodia, S., Sandur, S. K., Pandey, M. K., and Sethi, G. (2006) Inflammation and cancer. How hot is the link? Biochem. Pharmacol. 72, 1605-1621.
19. Biran, H., Friedman, N., Neumann, L., Pras, M., and Shainkin-Kestenbaum, R. (1986) Serum amyloid A (SAA) variations in patients with cancer: Correlation with disease activity, stage, primary site, and prognosis, J. Clin. Pathol. 39, 794-797.
20. Kindy, M. S., Yu, J., Guo, J. T., and Zhu, H. (1999) Apolipoprotein Serum Amyloid A in Alzheimer's Disease, J. Alzheimer's Dis. 1, 155-167.
21. Urieli-Shoval, S., Linke, R. P., and Matzner, Y. (2000) Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states, Curr. Opin. Hematol. 7, 64-69.
22. Chung, T. F., Sipe, J. D., McKee, A., Fine, R. E., Schreiber, B. M., Liang, J. S., and Johnson, R. J. (2000) Serum amyloid A in Alzheimer's disease brain is predominantly localized to myelin sheaths and axonal membrane, Amyloid 7, 105-110.
23. Cunnane, G. (2001) Amyloid proteins in pathogenesis of AA amyloidosis, Lancet 358, 4-5.
24. Gillmore, J. D., Lovat, L. B., Persey, M. R., Pepys, M. B., and Hawkins, P. N. (2001) Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein, Lancet 358, 24-29.
25. Levin, M., Franklin, E. C., Frangione, B., and Pras, M. (1972) The amino acid sequence of a major nonimmunoglobulin component of some amyloid fibrils, J. Clin. Invest. 51, 2773-2776.
26. Husebekk, A., Skogen, B., Husby, G., and Marhaug, G. (1985) Transformation of amyloid precursor SAA to protein AA and incorporation in amyloid fibrils in vivo, Scand. J. Immunol. 21, 283-287.
27. Ericsson, L. H., Eriksen, N., Walsh, K. A., and Benditt, E. P. (1987) Primary structure of duck amyloid protein A. The form deposited in tissues may be identical to its serum precursor, FEBS Lett. 218, 11-16.
28. Wang, L., Lashuel, H. A., Walz, T., and Colon, W. (2002) Murine apolipoprotein serum amyloid A in solution forms a hexamer containing a central channel, Proc. Natl. Acad. Sci. U.S.A. 99, 15947-15952.
29. Wang, L., and Colon, W. (2005) Urea-induced denaturation of apolipoprotein serum amyloid A reveals marginal stability of hexamer, Protein Sci. 14, 1811-1817.
30. Wang, L., Lashuel, H. A., and Colon, W. (2005) From hexamer to amyloid: Marginal stability of apolipoprotein SAA2.2 leads to in vitro fibril formation at physiological temperature, Amyloid 12, 139-148.
31. Wang, L., and Colón, W. (2004) The interaction between apolipoprotein serum amyloid A and high-density lipoprotein, Biochem. Biophys. Res. Commun. 317, 157-161.
32. Sobocinski, P. Z., Canterbury, W. J., Jr., Hauer, E. C., and Beall, F. A. (1979) Induction of hypozincemia and hepatic metallothionein synthesis in hypersensitivity reactions, Proc. Soc. Exp. Biol. Med. 160, 175-179.
33. Kushner, I. (1982) The phenomenon of the acute phase response, Ann. N.Y. Acad. Sci. 389, 39-48.
34. Fraker, P. J., King, L. E., Laakko, T., and Vollmer, T. L. (2000) The dynamic link between the integrity of the immune system and zinc status, J. Nutr. 130, 1399S-1406S.
35. Rink, L., and Gabriel, P. (2000) Zinc and the immune system, Proc. Nutr. Soc. 59, 541-552.
36. Dardenne, M. (2002) Zinc and immune function, Eur. J. Clin. Nutr. 56 (Suppl. 3), S20-S23.
37. Ibs, K. H., and Rink, L. (2003) Zinc-altered immune function, J. Nutr. 133, 1452S-1456S.
38. Conforti, A., Franco, L., Milanino, R., Totorizzo, A., and Velo, G. P. (1983) Copper metabolism during acute inflammation: Studies on liver and serum copper concentrations in normal and inflamed rats, Br. J. Pharmacol. 79, 45-52.
39. Oliva, J. C., Castell, M., Queralt, J., and Castellote, C. (1987) Effect of chronic inflammation on copper and zinc metabolism, Rev. Esp. Fisiol. 43, 25-31.
40. Lei, K. Y. (1991) Dietary copper: Cholesterol and lipoprotein metabolism, Annu. Rev. Nutr. 11, 265-283.
41. Kisilevsky, R., and Subrahmanyan, L. (1992) Serum amyloid A changes high density lipoprotein's cellular affinity. A clue to serum amyloid A's principal function, Lab. Invest. 66, 778-785.
42. Liang, J. S., Schreiber, B. M., Salmona, M., Phillip, G., Gonnerman, W. A., de Beer, F. C., and Sipe, J. D. (1996) Amino terminal region of acute phase, but not constitutive, serum amyloid A (apoSAA) specifically binds and transports cholesterol into aortic smooth muscle and HepG2 cells, J. Lipid Res. 37, 2109-2116.
43. Turnell, W., Sarra, R., Glover, I. D., Baum, J. O., Caspi, D., Baltz, M. L., and Pepys, M. B. (1986) Secondary structure prediction of human SAA1. Presumptive identification of calcium and lipid binding sites, Mol. Biol. Med. 3, 387-407.
44. Kula, R. W., Engel, W. K., and Line, B. R. (1977) Scanning for soft-tissue amyloid, Lancet 1, 92-93.
45. Danielsen, B., Sorensen, I. J., Nybo, M., Nielsen, E. H., Kaplan, B., and Svehag, S. E. (1997) Calcium-dependent and -independent binding of the pentraxin serum amyloid P component to glycosaminoglycans and amyloid proteins: Enhanced binding at slightly acid pH, Biochim. Biophys. Acta 1339, 73-78.
46. Jobling, M. F., Huang, X., Stewart, L. R., Barnham, K. J., Curtain, C., Volitakis, I., Perugini, M., White, A. R., Cherny, R. A., Masters, C. L., Barrow, C. J., Collins, S. J., Bush, A. I., and Cappai, R. (2001) Copper and zinc binding modulates the aggregation and neurotoxic properties of the prion peptide PrP106-126, Biochemistry 40, 8073-8084.
47. Millhauser, G. L. (2004) Copper binding in the prion protein, Acc. Chem. Res. 37, 79-85.
48. Atwood, C. S., Moir, R. D., Huang, X., Scarpa, R. C., Bacarra, N. M., Romano, D. M., Hartshorn, M. A., Tanzi, R. E., and Bush, A. I. (1998) Dramatic aggregation of Alzheimer Aβ by Cu(II) is induced by conditions representing physiological acidosis, J. Biol. Chem. 273, 12817-12826.
49. Liu, S. T., Howlett, G., and Barrow, C. J. (1999) Histidine-13 is a crucial residue in the zinc ion-induced aggregation of the Aβ peptide of Alzheimer's disease, Biochemistry 38, 9373-9378.
50. House, E., Collingwood, J., Khan, A., Korchazkina, O., Berthon, G., and Exley, C. (2004) Aluminium, iron, zinc and copper influence the in vitro formation of amyloid fibrils of Aβ42 in a manner which may have consequences for metal chelation therapy in Alzheimer's disease, J. Alzheimer's Dis. 6, 291-301.
51. Cuajungco, M. P., Frederickson, C. J., and Bush, A. I. (2005) Amyloid-β metal interaction and metal chelation, Subcell. Biochem. 38, 235-254.
52. Khan, A., Ashcroft, A. E., Higenell, V., Korchazhkina, O. V., and Exley, C. (2005) Metals accelerate the formation and direct the structure of amyloid fibrils of NAC, J. Inorg. Biochem. 99, 1920-1927.
53. Isaacs, A. M., Senn, D. B., Yuan, M., Shine, J. P., and Yankner, B. A. (2006) Acceleration of amyloid β-peptide aggregation by physiological concentrations of calcium, J. Biol. Chem. 281, 27916-27923.
54. Paik, S. R., Shin, H. J., Lee, J. H., Chang, C. S., and Kim, J. (1999) Copper(II)-induced self-oligomerization of α-synuclein, Biochem. J. 340 (Part 3), 821-828.
55. Uversky, V. N., Li, J., and Fink, A. L. (2001) Metal-triggered structural transformations, aggregation, and fibrillation of human α-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure, J. Biol. Chem. 276, 44284-44296.
56. Lowe, R., Pountney, D. L., Jensen, P. H., Gai, W. P., and Voelcker, N. H. (2004) Calcium(II) selectively induces α-synuclein annular oligomers via interaction with the C-terminal domain, Protein Sci. 13, 3245-3252.
57. Eakin, C. M., Knight, J. D., Morgan, C. J., Gelfand, M. A., and Miranker, A. D. (2002) Formation of a copper specific binding site in non-native states of β-2-microglobulin, Biochemistry 41, 10646-10656.
58. Eakin, C. M., and Miranker, A. D. (2005) From chance to frequent encounters: Origins of β2-microglobulin fibrillogenesis, Biochim. Biophys. Acta 1753, 92-99.
59. Liang, J., Elliott-Bryant, R., Hajri, T., Sipe, J. D., and Cathcart, E. S. (1998) A unique amyloidogenic apolipoprotein serum amyloid A (apoSAA) isoform expressed by the amyloid resistant CE/J mouse strain exhibits higher affinity for macrophages than apoSAA1 and apoSAA2 expressed by amyloid susceptible CBA/J mice, Biochim. Biophys. Acta 1394, 121-126.
60. Craig, W. S. (1988) Determination of quaternary structure of an active enzyme using chemical cross-linking with glutaraldehyde, Methods Enzymol. 156, 333-345.
61. Hajri, T., Elliott-Bryant, R., Sipe, J. D., Liang, J. S., Hayes, K. C., and Cathcart, E. S. (1998) The acute phase response in apolipoprotein A-1 knockout mice: Apolipoprotein serum amyloid A and lipid distribution in plasma high density lipoproteins, Biochim. Biophys. Acta 1394, 209-218.
62. Aruoma, O. I., Reilly, T., MacLaren, D., and Halliwell, B. (1988) Iron, copper and zinc concentrations in human sweat and plasma: The effect of exercise, Clin. Chim. Acta 177, 81-87.
63. Rukgauer, M., Klein, J., and Kruse-Jarres, J. D. (1997) Reference values for the trace elements copper, manganese, selenium, and zinc in the serum/plasma of children, adolescents, and adults, J. Trace Elem. Med. Biol. 11, 92-98.
64. Brown, K. H. (1998) Effect of infections on plasma zinc concentration and implications for zinc status assessment in low-income countries, Am. J. Clin. Nutr. 68, 425S-429S.
65. Lester, E., and Varghese, Z. (1977) Differences in the calcium concentration of serum and plasma initially and after storage, Ann. Clin. Biochem. 14, 39-44.
66. Boetefur, A. K., and Muller-Plathe, O. (1995) Evaluation of a new method for determining the total calcium concentration using diluted plasma and an ion-selective electrode, Eur. J. Clin. Chem. Clin. Biochem. 33, 749-754.
67. Agrimi, U., and Di Guardo, G. (1993) Amyloid, amyloid-inducers, cytokines and heavy metals in scrapie and other human and animal subacute spongiform encephalopathies: Some hypotheses, Med. Hypotheses 40, 113-116.